| Fabrazyme Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Fabrazyme 35 mg | powder for injection | intravenous | 1.0 each | OTC |
| Fabrazyme 5 mg | powder for injection | intravenous | 1.0 each | OTC |
Biotech Company Specializes In Treatments For Rare Disorders - CNNMoney.com
Genzyme also makes Fabrazyme, which generated $114 million in sales last quarter, up 18%, and $424 million for the year. The drug helps treat Fabry's ...
Wed Jan 23 20:12:43 +0000 2008
Fabry's drug outlook sinks Amicus shares - Trading Markets (press release)
s Fabrazyme. Shares plunged $5.59, or 37 percent, to close at $9.54 Thursday, having hit a new 52-week low of $9.20 earlier in the session. ...
Thu Dec 20 21:04:06 +0000 2007
Genzyme 'bullish' on future growth - Boston Globe
Fabrazyme, a treatment for Fabry disease, increased 18 percent to $114 million. Genzyme's drugs for rare hereditary disorders treat illnesses caused by a ...
Wed Jan 09 01:23:16 +0000 2008
agalsidase beta